Trial Profile
Insulin detemir (Levemir) versus isophane (NPH) insulin [insulin suspension isophane] (Protaphane) in combination with oral antidiabetic agents (OAD) in patients with diabetes mellitus type 2 comparing treatment satisfaction, diabetes-related and general health-related quality of life, as well as diabetes-control.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 18 Nov 2009 Actual patient number chnaged from 7712 to 8125 as reported by ClinicalTrials.gov.
- 16 Oct 2009 Actual patient number (7712) added as reported by ClinicalTrials.gov.
- 08 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.